Challenges in the clinical and economic evaluation of medical devices: The case of transcatheter aortic valve implantation

Journal of Medical Marketing

Volumn 11, Issue 3, 2011, Pages 221-229

  Tarricone, Rosanna ^a   Drummond, Michael ^b  

^a BOCCONI UNIVERSITY   (Italy)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Alur; economic evaluation 2; HTA; medical devices; S.; Sivakumar T; TAVI

Indexed keywords

EID: 80054848100     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1177/1745790411412242     Document Type: Article

References (22)

1. Drummond M, Griffin A and Tarricone R. Economic evaluation for devices and drugs-same or different? Value Health 2009; 12(4): 402-404.
2. Dewey TM, Brown DL, Das TS, Ryan WH, Fowler JE, Hoffman SD, Prince SL, Herbert MA, Culica D and Mack MJ. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 2008; 86(5): 1450-1456.
3. Otten AM, van Domburg RT, Serruys PW, Kappetein AP, Takkenberg JJ, Bogers AJ, Serruys PW and de Jaegere PP. Population characteristics, treatment assignment and survival of elderly patients with aortic stenosis referred for percutaneous valve replacement. Circulation 2008; 118: S806-S807.
4. Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Ruckert Y, Ender J, Linke A, Scholz M, Falk V and Mohr FW. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity matched conventional aortic valve replacement. Eur Heart J 2010; 31(11): 1398-1403.
5. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Lung G, Donzeau-Gouge P, Tribouilloy C, Debrux J-L, Pavie A and Gueret P. on behalf of the FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur Heart J 2010; September 15: 1-7.
6. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D and Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55(11): 1080-1090.
7. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN and Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122(1): 62-69.
8. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A and Webb JG. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010; 122(13): 1319-1327.
9. Edwards Lifesciences (2007). The PARTNER-US IDE Trial. Investigational Plan Summary.
10. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D and Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med 2010; 363(17): 1597-1607.
11. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Piérard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK and Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29(11): 1463-1470.
12. Di Eusanio M, Fortuna D, De Palma R, Dell'Amore A, Lamarra M, Contini GA, Gherli T, Gabbieri D, Ghidoni I, Cristell D, Zussa C, Pigini F, Pugliese P, Pacini D and Di Bartolomeo R. Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2010; 2.
13. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A and Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009; 53(20): 1855-1858.
14. Wendler O, Walther T, Nataf P, Rubino P, Schroefel H, Thielmann M, Treede H and Thomas M. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg 2010; 38(2): 119-127.
15. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S and Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving System. Circ Cardiovasc Interv 2008; 1: 167-175.
16. Ramsay CR, Grant AM,Wallace SA, Garthwaite PH, Monk AF and Russell IT. Assessment of the learning curve in health technologies. A systematic review. Int J Technol Assess Health Care 2000; 16(4): 1095-1108.
17. Rice N and Jones A. Multilevel models and health economics. Health Econ 1997; 6(6): 561-575. (Pubitemid 28021622)
18. Manca A, Rice N, Sculpher MJ and Briggs AH. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ 2005; 14(5): 471-485. (Pubitemid 40723855)
19. KCE. Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment. KCE Reports 95C, 2008.
20. Haute Autorite de Sante. Edwards SAPIEN 9000TFX. Committee for Assessment of Medical Products and Services. Opinion of the Committee, 12 December 2007.
21. Sculpher M, Drummond MF and Buxton MJ. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 1997; 2(1): 26-30. (Pubitemid 27077650)
22. Claxton K and Posnett J. An economic approach to clinical trial design and research priority setting. Health Econ 2006; 5: 513-524.